Masaki Baba

1.4k total citations
45 papers, 1.2k citations indexed

About

Masaki Baba is a scholar working on Molecular Biology, Pharmacology and Plant Science. According to data from OpenAlex, Masaki Baba has authored 45 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 14 papers in Pharmacology and 14 papers in Plant Science. Recurrent topics in Masaki Baba's work include Pharmacological Effects of Natural Compounds (13 papers), Natural product bioactivities and synthesis (12 papers) and Ginseng Biological Effects and Applications (7 papers). Masaki Baba is often cited by papers focused on Pharmacological Effects of Natural Compounds (13 papers), Natural product bioactivities and synthesis (12 papers) and Ginseng Biological Effects and Applications (7 papers). Masaki Baba collaborates with scholars based in Japan, Türkiye and United Kingdom. Masaki Baba's co-authors include Toru Okuyama, Hoyoku Nishino, Yoshihito Okada, Tetsuyuki Takahashi, Hisahiro Kai, Nobuo Takasuka, Hiroyuki Tsuda, Yoshiko Satomi, Masaaki Iigo and Alev Tosun and has published in prestigious journals such as Proceedings of the National Academy of Sciences, American Journal Of Pathology and Molecules.

In The Last Decade

Masaki Baba

43 papers receiving 1.1k citations

Peers

Masaki Baba
Soon Sung Lim South Korea
Dejan Nikolić United States
Jutta Knauft Germany
Quan Le Tran Vietnam
Ju Sun Kim South Korea
Soon Sung Lim South Korea
Masaki Baba
Citations per year, relative to Masaki Baba Masaki Baba (= 1×) peers Soon Sung Lim

Countries citing papers authored by Masaki Baba

Since Specialization
Citations

This map shows the geographic impact of Masaki Baba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaki Baba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaki Baba more than expected).

Fields of papers citing papers by Masaki Baba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaki Baba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaki Baba. The network helps show where Masaki Baba may publish in the future.

Co-authorship network of co-authors of Masaki Baba

This figure shows the co-authorship network connecting the top 25 collaborators of Masaki Baba. A scholar is included among the top collaborators of Masaki Baba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaki Baba. Masaki Baba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kawanishi, Kunio, Masaki Baba, Dedong Kang, et al.. (2024). Acute Tubular Injury and Fanconi Syndrome Associated With Red Yeast Rice Supplement. Kidney International Reports. 10(3). 956–959.
2.
Kawanishi, Kunio, et al.. (2024). A Novel Deep Learning Approach for Analyzing Glomerular Basement Membrane Lesions in a Mouse Model of X-Linked Alport Syndrome. American Journal Of Pathology. 195(1). 143–154. 1 indexed citations
3.
Baba, Masaki, Hiroshi Odaguchi, Toshihiko Hanawa, et al.. (2022). Kampo Formula-Pattern Models: The Development of 13 New Clinically Useful Standard Abdominal Pattern Models in the Fukushin Simulator. Frontiers in Pharmacology. 13. 688074–688074. 3 indexed citations
4.
Zhang, Lin, Huiyuan Gao, Masaki Baba, et al.. (2014). Extracts and compounds with anti-diabetic complications and anti-cancer activity from Castanea mollissina Blume (Chinese chestnut). BMC Complementary and Alternative Medicine. 14(1). 422–422. 40 indexed citations
5.
Fukuda, Eriko, Yoshihiro Uesawa, Masaki Baba, et al.. (2014). Identification of the Country of Growth of Sophora flavescens using Direct Analysis in Real Time Mass Spectrometry (DART-MS). Natural Product Communications. 9(11). 1591–4. 4 indexed citations
6.
Baba, Masaki, et al.. (2012). New triterpenoid saponins from cacti and anti-type I allergy activity of saponins from cactus. Bioorganic & Medicinal Chemistry Letters. 22(14). 4793–4800. 14 indexed citations
7.
Miyazaki, Toshitsugu, et al.. (2011). Antidiabetic effect of polyphenols from brown algaEcklonia kuromein genetically diabetic KK-Aymice. Pharmaceutical Biology. 50(3). 393–400. 30 indexed citations
8.
Baba, Masaki, et al.. (2010). The constituents ofUrtica cannabinaused in Uighur medicine. Pharmaceutical Biology. 48(5). 577–583. 14 indexed citations
9.
Kai, Hisahiro, Masaki Baba, & Toru Okuyama. (2008). Inhibitory Effect ofCucumis sativuson Melanin Production in Melanoma B16 Cells by Downregulation of Tyrosinase Expression. Planta Medica. 74(15). 1785–1788. 23 indexed citations
10.
Kai, Hisahiro, Masaki Baba, & Toru Okuyama. (2007). Two New Megastigmanes from the Leaves of Cucumis sativus. Chemical and Pharmaceutical Bulletin. 55(1). 133–136. 73 indexed citations
11.
Tosun, Alev, et al.. (2005). Pyranocoumarins from Seseli gummiferum subsp. corymbosum Growing in Turkey. DergiPark (Istanbul University). 22 indexed citations
12.
Shimizu, Kazuo, et al.. (2005). Dietary artepillin C suppresses the formation of aberrant crypt foci induced by azoxymethane in mouse colon. Cancer Letters. 240(1). 135–142. 27 indexed citations
13.
Takahashi, Tetsuyuki, Nobuo Takasuka, Masaaki Iigo, et al.. (2004). Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development. Cancer Science. 95(5). 448–453. 160 indexed citations
14.
Tosun, Alev, et al.. (2003). Coumarins from Seseli gummiferum Pall, ex Sin. subsp. corymbosum P. H. Davis. Natural medicines = 生薬學雜誌. 57(3). 117. 3 indexed citations
15.
Ii, Tsunehiro, Yoshiko Satomi, Junichi Shimada, et al.. (2003). Induction of cell cycle arrest and p21CIP1/WAF1 expression in human lung cancer cells by isoliquiritigenin. Cancer Letters. 207(1). 27–35. 81 indexed citations
16.
Kanazawa, Motohiro, Yoshiko Satomi, Yoichi Mizutani, et al.. (2003). Isoliquiritigenin Inhibits the Growth of Prostate Cancer. European Urology. 43(5). 580–586. 131 indexed citations
17.
Yamazaki, Shoji, Hitoshi Endo, Toshiro Hamamoto, et al.. (2002). Isoliquiritigenin suppresses pulmonary metastasis of mouse renal cell carcinoma. Cancer Letters. 183(1). 23–30. 99 indexed citations
18.
Baba, Masaki, Naoki Kishi, Yoshihito Okada, et al.. (2000). Saponins Isolated from Allium chinense G. DON and Antitumor-promoting Activities of Isoliquiritigenin and Laxogenin from the Same Drug.. Biological and Pharmaceutical Bulletin. 23(5). 660–662. 48 indexed citations
19.
Onozawa, Mizuki, Toshihiko Kawamori, Masaki Baba, et al.. (1999). Effects of a Soybean Isoflavone Mixture on Carcinogenesis in Prostate and Seminal Vesicles of F344 Rats. Japanese Journal of Cancer Research. 90(4). 393–398. 65 indexed citations
20.
Okuyama, Toru, et al.. (1995). Studies on the Cancer Chemoprevention of Natural Resources. XI : Anti-Tumor Promoting Activities of Crude Drug "Xiebai" and Kampo Prescriptions COmposed of "Xiebai". 49(3). 261–265. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026